News | October 28, 2013

GE’s somo•v Automated Breast Ultrasound System Ranked No. 1 in Women’s Best in KLAS Awards

October 28, 2013 — GE Healthcare announced that the somo•v Insight System was recognized as the category leader with the highest ranking in Women’s Imaging (Specialty) in the 2013 Best in KLAS Awards: Medical Equipment and Infrastructure Report. The Best in KLAS Awards Report ranked imaging, pharmacy automation and infrastructure vendors. This year, healthcare providers ranked over 180 products.
 
KLAS independently monitors vendor performance through the active participation of thousands of healthcare organizations. KLAS Performance Data represents the opinions of healthcare executives, managers and clinicians from over 4,500 hospitals and 2,500 clinics who have rated over 750 products and services from more than 200 vendors.
 
Using proprietary technology to automate the ultrasound imaging process, the somo•v automated breast ultrasound system (ABUS) system was developed specifically for the breast cancerscreening environment. Demonstrating a 35.7 percent improvement in cancer detection (sensitivity), the somo•v ABUS system is the only ultrasound device approved for breast cancer screening in the United States as an adjunct to mammography for asymptomatic women with dense breast tissue who have not had prior breast intervention.
 
One study, published in the New England Journal of Medicine, showed mammography sensitivity is reduced by 36 to 38 percent in women with dense breasts, as density masks the appearance of tumors (Boyd, et al, NEJM 2007:356:227-36M). As breast density goes up, the accuracy of mammograms goes down.
 
“We needed additional screening tools to improve breast cancer detection in women with dense breasts and ABUS has been proven to be beneficial and is easy to use,” said Marc Inciardi, M.D., breast imaging radiologist, University of Kansas Cancer Center in Kansas City, Mo. and consultant, GE Healthcare. “Enhancing our breast imaging capabilities without increasing the radiation dose, ABUS has quickly become a useful supplementary breast cancer detection tool in our practice.”
 

Related Content

Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Overlay Init